Drug Free Solution Stock Market Value
| DSOL Stock | USD 0 0.00 0.00% |
| Symbol | Drug |
Drug Free 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drug Free's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drug Free.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Drug Free on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Drug Free Solution or generate 0.0% return on investment in Drug Free over 90 days. Drug Free is related to or competes with Novacyt SA, Medical Developments, Leef Brands, Theralase Technologies, and Cynata Therapeutics. Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breat... More
Drug Free Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drug Free's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drug Free Solution upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.099 | |||
| Maximum Drawdown | 27.27 |
Drug Free Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drug Free's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drug Free's standard deviation. In reality, there are many statistical measures that can use Drug Free historical prices to predict the future Drug Free's volatility.| Risk Adjusted Performance | 0.1075 | |||
| Jensen Alpha | 0.3522 | |||
| Total Risk Alpha | 0.1108 | |||
| Treynor Ratio | 0.5593 |
Drug Free February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1075 | |||
| Market Risk Adjusted Performance | 0.5693 | |||
| Mean Deviation | 0.8139 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 3.36 | |||
| Variance | 11.27 | |||
| Information Ratio | 0.099 | |||
| Jensen Alpha | 0.3522 | |||
| Total Risk Alpha | 0.1108 | |||
| Treynor Ratio | 0.5593 | |||
| Maximum Drawdown | 27.27 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Drug Free Solution Backtested Returns
Drug Free appears to be out of control, given 3 months investment horizon. Drug Free Solution secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for Drug Free Solution, which you can use to evaluate the volatility of the firm. Please utilize Drug Free's Variance of 11.27, mean deviation of 0.8139, and Standard Deviation of 3.36 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Drug Free holds a performance score of 10. The firm shows a Beta (market volatility) of 0.72, which means possible diversification benefits within a given portfolio. As returns on the market increase, Drug Free's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drug Free is expected to be smaller as well. Please check Drug Free's treynor ratio and day median price , to make a quick decision on whether Drug Free's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Drug Free Solution has no correlation between past and present. Overlapping area represents the amount of predictability between Drug Free time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drug Free Solution price movement. The serial correlation of 0.0 indicates that just 0.0% of current Drug Free price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.